| Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis | |
| Zhang, Zulei; Chen, Yuting; Jiang, Yaofei; Luo, Yan; Zhang, Hao; Zhan, Yakun | |
| 刊名 | CANCER BIOLOGY & THERAPY
 |
| 2019 | |
| 卷号 | 20期号:11 |
| 关键词 | CXCL1 GRO alpha cancer prognosis |
| ISSN号 | 1538-4047 |
| DOI | 10.1080/15384047.2019.1647056 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4233782 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Zhang, Zulei,Chen, Yuting,Jiang, Yaofei,et al. Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis[J]. CANCER BIOLOGY & THERAPY,2019,20(11). |
| APA | Zhang, Zulei,Chen, Yuting,Jiang, Yaofei,Luo, Yan,Zhang, Hao,&Zhan, Yakun.(2019).Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis.CANCER BIOLOGY & THERAPY,20(11). |
| MLA | Zhang, Zulei,et al."Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis".CANCER BIOLOGY & THERAPY 20.11(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论